GGrantIndex
Sort

39,280 grants matching leukemia

Computational Tools for Next Generation Volumetric Cone Beam Computed Tomography

$501,863
Lei Xing · Stanford University · R01 · FY2014 · EB

Therapeutic targeting of IRAK4 in MDS

$501,623
Amit Verma · Albert Einstein College Of Medicine · R01 · FY2024 · CA

Clinical Investigation of Epigenetic Therapy

$501,619
John C Byrd · Ohio State University · P01 · FY2010 · CA

Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy

$501,567
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

Biofunctional Polymers for Intracellular Drug Delivery

$501,491
Patrick S. Stayton · University Of Washington · R01 · FY2009 · EB

O-Glycosylation of Epidermal Growth Factor-like Motifs

$501,447
Robert S. Haltiwanger · University Of Georgia · R01 · FY2018 · GM

PRE-AND POSTGRADUATE TRAINING IN MOLECULAR HEMATOLOGY

$501,400
Stephen Tracy Oh · Washington University · T32 · FY2019 · HL

Novel Mcl-1 inhibitors for overcoming therapeutic resistance in colorectal cancer

$501,374
Zaneta Nikolovska-Coleska · University Of Michigan At Ann Arbor · R01 · FY2019 · CA

Tumor cell metabolism in action

$501,299
Eileen White · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA

Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies

$501,285
John C Byrd · Ohio State University · R01 · FY2018 · CA

Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia

$501,244
Jiyang Yu · St. Jude Children'S Research Hospital · U01 · FY2024 · CA

Anticancer Agent Pharmacodynamics in Acute Leukemia

$501,228
St. Jude Children'S Research Hospital · R01 · FY2004 · CA

Mechanisms of the spliceosome protein SF3B1 and inhibitors

$501,161
Melissa S Jurica · University Of California Santa Cruz · R01 · FY2020 · GM

MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER

$501,149
Marco Ruella · University Of Pennsylvania · R37 · FY2024 · CA

Human Decidual Leukocytes and Their Placental Ligands

$501,110
Jack L Strominger · Harvard University · R01 · FY2011 · AI

Metabolic Syndrome Following Transplant for Leukemia

$501,100
Kevin S Baker · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA

Predictors of myelodysplastic syndrome in Minnesota

$501,057
Julie Ann Ross · University Of Minnesota · R01 · FY2013 · CA

Intervention Trials in Persons at Increased Genetic Risk of Cancer

$500,914
Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA

Repeat enhancers as drivers of ETV6-RUNX1+ and ETV6-RUNX1-like B-lymphoblastic leukemia

$500,719
Russell James Hubbard Ryan · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

CANCER AND LEUKEMIA GROUP B

$500,685
Dana-Farber Cancer Institute · U10 · FY2002 · CA

Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio

$500,640
Claudio Anasetti · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · HL

Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia

$500,620
Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2024 · CA

Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies

$500,541
John C Byrd · Ohio State University · R01 · FY2014 · CA

Study of the Roles of SDF1 and CXCR4 in Hematopoiesis

$500,541
Giovanna Tosato · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Early Immune Development and Function in Neonates Exposed to Maternal HIV Infection

$500,504
Huanbin Xu · Tulane University Of Louisiana · R01 · FY2021 · AI